Clinical Trial Update: A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for SHR-1905 in subjects with severe uncontrolled asthma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• SHR-1905

Snippet

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. | Conditions: Asthma | Phase 2 | Status: ACTIVE_NOT_RECRUITING